IDH1 R132 mutations have been found to occur in 55-80% of grade II and III oligodendrogliomas and astrocytomas. IDH1 mutations are rare in primary GBM (<10%) but are frequently observed in secondary GBM (>80%). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).